Holly Jeong '17, Author at Dartmouth Business Journal

Boston Beer Co.: Winning in a World of Big Bad Beers

This article was co-published by Seeking Alpha on Nov. 22, 2015.

After months of playing hard to get, SABMiller (SBMRY) has agreed to a $55 billion takeover by its biggest rival, AB InBev (BUD). AB InBev will offer most SABMiller ... Continue reading...

Technology

Getting to Know You Better

It is no secret that networking giants such as Google and Facebook rely heavily on consumer-generated data to keep business thriving. They charge businesses for featuring ads tailored to consumer preferences, based on information willingly provided by the individual, previous... Continue reading...

Consumer

Demystifying the Alibaba Phenomenon

Mention “Alibaba” and people tend to associate it with two things. First, that it completed the largest Initial Public Offering (IPO) in history with $25 billion (compared to Facebook’s $16 billion). Second, that it is an e-commerce company that threatens... Continue reading...

Consumer

Starbucks Catalyzes Pumpkin Boom

Could the meteoric rise in popularity of the Starbucks Pumpkin Spice Latte have catalyzed a “Pumpkin Boom”? The recent craze for everything pumpkin and a correlated rise in pumpkin sales begs the seductive question of whether a seasonal, brand-specific drink... Continue reading...

Dartmouth Business Journal

Boston Beer Co.: Winning in a World of Big Bad Beers

Getting to Know You Better

Demystifying the Alibaba Phenomenon

Starbucks Catalyzes Pumpkin Boom

Popular

Foreign Direct Investment in Nigeria

Singapore’s Market-Model Healthcare System

Automation: The End of the Middle Class?

Syrian Refugees: From Burden to Benefit

Is Crude Drilling South or Barreling North?

David and Goliath: Is Fintech a Threat to the Financial Behemoths?

Random

The Rise of Passive Investment: Is Doing Less Better?

The Negative Interest Rate: A Venture into Uncertainty

Automated Investment Platforms

The Dodd-Frank Bill: Reassessing “Reform”

Net Neutrality: The Ramifications of Verizon v. FCC

Pharmaceutical Giants & Biotech Firms: Happily Ever After?